BFM 89.9

HIGHLIGHTS 
Podcast  >  Morning Run  >  Morning Brief  >  A Happy Tear Shed For Virus Efficacy

A Happy Tear Shed For Virus Efficacy

Sam Fazeli, Senior Healthcare Analyst, Bloomberg Intelligence

19-Nov-20 07:37

A Happy Tear Shed For Virus Efficacy

Pfizer may be the first drugmaker to file for US regulatory authorization for its Covid-19 vaccine, which it says is 95% effective with no serious side effects. This comes right on the heels of news out of Moderna, which says its vaccine also stands at over 94%. With hopes rising that we may see a vaccine in distribution by the end of the year, we speak to Sam Fazeli, Senior Healthcare Analyst at Bloomberg Intelligence, about whether this is truly a cause for excitement.

Image Credit: Shutterstock

Produced by: Dayana Mustak

Presented by: Lyn Mak, Roshan Kanesan, Wong Shou Ning


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  PoliticsLaw and Legal MattersHealth PolicyDiseases and ConditionsMental HealthHealthy LivingFitnessScienceBusiness AnalysisTrends and ForecastsMarketsSocial IssuesMedical Innovation and TechnologyInvestments

Tags:  vaccinecovid-19distributionuspfizermodernaastrazenecahealthcare





Play / Pause

Listen now : BFM 89.9 -- The Business Station

Today’s Shows